Navigation Links
Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting
Date:9/27/2007

More than 3,000 leading scientists and clinicians to present advances in CF research and care

ANAHEIM, Calif., Sept. 27 /PRNewswire-USNewswire/ --- An international medical meeting will draw more than 3,000 cystic fibrosis experts from all fields of science and medicine to Anaheim Oct. 3 - 6, 2007 to present the latest information and advances in cystic fibrosis drug research and care.

The 21st annual North American Cystic Fibrosis Conference is an annual ritual for leading CF research scientists and clinicians to collaborate in an open and noncompetitive environment. Key topics will include:

-- Advancements in drug discovery and development and the importance of

clinical trials;

-- Aztreonam lysine for inhalation as a potential new CF therapy;

-- Quality improvement and patient outcomes;

-- The importance of newborn screening; and

-- Serving the Hispanic CF population in the U.S.

Cystic fibrosis is a life-threatening genetic disease that affects approximately 30,000 children and adults in the United States. Ten million people are unknowing carriers of a CF gene. Fifty years ago, most children with CF died before reaching elementary school. Today, because of Cystic Fibrosis Foundation-supported drug research and care, people with CF are living to a median predicated age of 37.

WHAT: The 21st Annual North American Cystic Fibrosis Conference, the largest international gathering of leading cystic fibrosis research scientists and clinicians.

WHEN & WHERE:

Wed., Oct. 3 - Sat., Oct. 6, 2007 at the Anaheim Convention Center, Anaheim, Calif.

PLENARY SESSION HIGHLIGHTS:

-- Thursday, Oct. 4, 4:20 p.m. - "From Basic Science to the Clinic: Where

Are We & What Is Still Missing?" Margarida D. Amaral, Ph.D.,

University of Lisbon, Lisbon, Portugal.

-- Friday, Oct. 5, 8:30 a.m. - "CF Drug Development: What's New?" Felix

Ratjen, M.D., Ph.D., The Hospital for Sick Children, Toronto, Ontario.

-- Sat., Oct. 6, 9:00 a.m. - "Improving Patient Outcomes Using the Tools

We Have Now" Michael Boyle, M.D., The Johns Hopkins Hospital,

Baltimore, Maryland.

INTERVIEWS AVAILABLE WITH:

Plenary speakers and other leading CF research scientists and clinicians

Robert J. Beall, Ph.D., President and CEO, Cystic Fibrosis Foundation

Preston W. Campbell, M.D., Executive Vice President for Medical Affairs, Cystic Fibrosis Foundation

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the leading organization devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation funds CF research, has 80 chapter and branch offices throughout the country, and supports and accredits a nationwide network of 115 CF care centers, which provide vital treatments and other CF resources to patients and families. For more information, visit http://www.cff.org.


'/>"/>
SOURCE Cystic Fibrosis Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Benefits Of The Worlds Most Widely Used Beverage
2. Worlds Largest Cord Blood Bank to be started in India
3. Australian Surgeons Successfully Conduct Worlds First Triple Organ Transplant
4. Worlds first mobile light surgery
5. Spanish Doctors Performs Worlds First Hand Transplantation Successfully
6. Worlds Heaviest Man Loses Weight Thanks to Monitored Dieting
7. Abu Dhabi to Have Worlds First Zero-carbon City
8. Eddie Murphy Voted Worlds Biggest Love-Rat
9. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press
10. India Has The Oldest And Largest Collection Of Preserved Mosquitoes – Mosquito Museu
11. Heart Related Problems-The Largest Killers In Andhra Pradesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Company LLC, announced the first national #QuackGivesBack campaign which supported local breast ... was our first franchise-wide Quack Gives Back initiative, and we’re very ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , Ginger Pigott ... LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach ... from the firm’s global Life Sciences & Medical Technology Group have been featured speakers ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has ... 2016 Top Workplaces National Standard. To learn ... ... (PRNewsFoto/Diplomat Pharmacy, Inc.) ... an employee survey administered by WorkplaceDynamics, LLC, a research firm specializing ...
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... Research and Markets has announced the addition of the "Global ... - Forecast to 2025" report to their offering. ... , , ... a CAGR of around 3.2% from 2015 to 2025. Some of ... extracellular microelectrode arrays and intracellular microelectrodes, research in left-to-right shunt detection ...
Breaking Medicine Technology: